There are no treatments or vaccines approved for Marburg, a virus in the same family as Ebola with a fatality rate between 24 ...
A similar vaccine, being developed at the University of Oxford, UK, was also named as a priority for testing during a Marburg ...
In a new study, the researchers used cryo-electron tomography to examine Ebola virus’s molecular structure to uncover targets for broadly effective antivirals. This work is published in Cell ...
Zacks Small Cap Research on MSN2d
SNGX: Marburg Outbreak Puts Focus on Soligenix Vaccine Development…(NASDAQ:SNGX) is developing vaccines targeting multiple filoviruses, including MarVax™, a heat stable vaccine for protection ...
Researchers have detailed the structure of the Ebola virus nucleocapsid using cryo-electron tomography. This discovery could ...
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...
Discover Moose Jaw News chatted with Dr. Darryl Falzarano, principal investigator at the University of Saskatchewan-based ...
Six people in Rwanda, primarily medical professionals, have died from the Marburg virus since the outbreak was declared. This ...
Six people have died, and 20 others are being treated for Marburg virus disease in Rwanda. This is the first-ever outbreak of ...
NanoViricides, Inc. (NYSE American.:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal ...
The nanoviricide thus "looks like" a cell to the virus ... Dengue fever, and Ebola virus, among others. NanoViricides' platform technology and programs are based on the TheraCour® nanomedicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback